Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Genoway S.A. Inh.

Start price
Target price
Perf. (%)
€4.37
07.11.21
€4.10
07.11.22
-19.68%
22.10.22

Could be worthwhile Investment >10% per year
Virbac S.A.

Start price
Target price
Perf. (%)
€401.50
07.11.21
€385.00
07.11.22
-38.36%
22.10.22

Could be worthwhile Investment >10% per year
Advicenne

Start price
Target price
Perf. (%)
€7.24
17.10.21
€6.00
17.10.22
-43.92%
18.10.22

Could be worthwhile Investment >10% per year
buy
Bayer AG

Start price
Target price
Perf. (%)
€43.96
06.12.21
€48.00
12.10.22
12.32%
13.10.22

Could be worthwhile Investment >10% per year
Inventiva SA

Start price
Target price
Perf. (%)
€11.54
10.09.21
€8.00
10.09.22
-63.65%
11.09.22

Could be worthwhile Investment >10% per year
buy
Molina Healthcare

Start price
Target price
Perf. (%)
€247.40
20.10.21
€280.00
31.12.23
39.05%
01.09.22

Could be very worthwhile Investment >20% year
buy
Humana Inc.

Start price
Target price
Perf. (%)
€390.10
20.10.21
€460.00
31.12.23
25.56%
01.09.22

Could be very worthwhile Investment >20% year
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€29.94
20.10.21
€35.00
31.12.23
65.15%
05.08.22

Could be very worthwhile Investment >20% year
buy
Global Blood Therapeutics Inc

Start price
Target price
Perf. (%)
€33.09
30.10.21
€45.00
31.12.23
94.65%
05.08.22

Could be very worthwhile Investment >20% year
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€152.65
16.11.21
€200.00
31.01.25
36.59%
03.08.22

Could be worthwhile Investment >10% per year
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.19
27.06.22
€1.00
27.06.23
26.17%
09.07.22

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
buy
Agile Therapeutics Inc.

Start price
Target price
Perf. (%)
€79.50
27.06.22
€100.00
27.06.23
40.88%
28.06.22

Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Little innovation
buy
Kezar Life Sciences

Start price
Target price
Perf. (%)
€10.20
16.11.21
€11.00
31.12.24
0.98%
28.06.22

Could be very worthwhile Investment >20% year
buy
Anthem Inc.

Start price
Target price
Perf. (%)
€363.90
20.10.21
€400.00
31.12.23
26.90%
28.06.22

Could be very worthwhile Investment >20% year
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€373.45
20.10.21
€450.00
31.12.23
28.49%
28.06.22

Could be very worthwhile Investment >20% year
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€9.23
09.11.21
€7.00
31.12.23
-56.18%
28.06.22

Could be very worthwhile Investment >20% year
buy
Cti Biopharma Corp

Start price
Target price
Perf. (%)
€2.47
17.10.21
€4.00
31.12.23
112.17%
28.06.22

Could be very worthwhile Investment >20% year
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.10
13.06.22
€1.00
13.06.23
7.81%
25.06.22

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€158.36
17.06.21
€165.00
17.06.22
59.60%
18.06.22

Could be worthwhile Investment >10% per year
buy
Hologic Inc.

Start price
Target price
Perf. (%)
€49.93
07.06.21
€55.00
07.06.22
42.14%
08.06.22

Could be worthwhile Investment >10% per year
buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€91.61
03.06.21
€115.00
03.06.22
34.21%
04.06.22

Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€74.55
07.05.21
€60.00
07.05.22
-37.42%
08.05.22

Higher EBIT margin than peer group
Probably not worthwhile Investment
Low dividend yield expected
Below average Management
buy
Zosano Pharma Corp.

Start price
Target price
Perf. (%)
€1.43
02.05.22
€1.00
02.05.23
18.02%
05.05.22

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Growths slower than the competition
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€81.20
03.05.21
€75.00
03.05.22
-41.82%
04.05.22

Could be worthwhile Investment >10% per year
buy
Centene Corp.

Start price
Target price
Perf. (%)
€51.00
01.05.21
€56.00
01.05.22
50.31%
02.05.22

Could be worthwhile Investment >10% per year